Epidermal growth factor receptor (EGFR) mutations are the most common driver gene mutations in lung cancers and are found in approximately 50% of lung adenocarcinomas in East Asians and in approximately 15% in Caucasians [2]. Here, EGFR is linked to lung carcinoma.